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Glycoprotein lib (GPIIb) 1 and glycoprotein Ilia (GPIIIa) are major constituents of 
the platelet membrane (1).  GPIIb and GPIIIa are markedly diminished or absent in 
platelets of patients with Glanzmann's thrombasthenia, a hereditary bleeding disorder 
characterized by an absence of fibrinogen binding and defective platelet aggregation 
(1-3). An IgG alloantibody obtained from a  transfused patient with thrombasthenia 
interacts with GPIIb and GPIIIa and induces a  thrombasthenia-like state in normal 
platelets  (4,  5).  Physiologic  stimulants  such  as  ADP,  epinephrine,  and  thrombin 
induce fibrinogen binding to normal platelets, which correlates with platelet aggre- 
gability (2, 6, 7). The evidence thus suggests that these two glyeoproteins are important 
in mediating platelet aggregation, probably by induction in the stimulated membrane 
of a  fibrinogen receptor.  We have recently reported the isolation of purified GPIIb 
and GPIIIa and the generation of monospecific antisera to these membrane proteins 
(8).  GPIIb and GPIIIa are antigenically different and structurally distinct  glycopro- 
teins.  In this study,  we present  direct  morphologic evidence demonstrating  macro- 
molecular complex formation of GPIIb and GPIIIa in  the platelet  membrane after 
thrombin stimulation. 
Materials and Methods 
Preparation of Washed Platelets.  A  suspension  of human  platelets was obtained  using the 
Ardlie buffer system modified as previously deeribed (9). 
Preparation of Antisera to Platelet Membrane Glycoprotein Ib (GPIb), GPIIb, and GPIIIa.  Antisera 
to GPIb (10), GPIIb, and GPIIIa (8)  were prepared in rabbits as described previously.  The 
antisera to GPIIb and GPIIIa were absorbed with washed platelets from a patient with classical 
Glanzmann's thrombasthenia (8). 
Preparation of F(ab')2 Fragments of Antisera.  The y-globulin fraction was prepared from each 
monospeeific  antiserum by ammonium sulfate precipitation followed  by triethylaminoethyl- 
cellulose column chromatography with phosphate buffer, pH 8.0, 0.0175 M. The -/-globulin 
fraction of goat anti-rabbit y-globulin was obtained commercially (Miles  Laboratories, Inc., 
Elkhart, Ind.). This fraction was further purified by triethylaminoethyl-cellulose chromatog- 
raphy using the same conditions as those used for the anti-glycoprotein antibodies. The purified 
y-globulin fraction of each antibody was digested with pepsin by the method of Nisonoff et al. 
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IIIa; KLH, keyhold limpet hemocyanin. 
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(11). The F(ab')2 fraction of each antibody was isolated by molecular sieve chromatography on 
Sephadex G-150 using normal saline buffered to pH 7.3. 
Ferritin Conjugation of Goat Anti-Rabbit `/-Globulin.  The F(ab')z fragment of the goat anti-rabbit 
-/-globulin was conjugated with ferritin by the method of Tawde and Ram (12).  Free ferritin 
and unconjugated y-globulin were separated from conjugated y-globulin by Pevikon (Mercer 
(2onsolidated Corp., Yonkers, N. Y.) block electrophoresis (13). 
Conjugation of Anti-GPIlb with Keyhold Limpet Hemocyanin (KLH).  The F(ab')2 fraction ofanti- 
GPIIb was conjugated with KLH by the method of Karnovsky et al. (14). 
Incubation of Platelets with Thrombin.  Washed platelets were suspended at 200,000/#1 in Ardlie 
buffer II in which bicarbonate was replaced with Tris (9). To 50 ml of the platelet suspension 
was added  12.5  U  purified thrombin kindly supplied by Dr. J.  Fenton II, New York State 
Department of Health, Albany, N. Y., and the mixture was incubated for 5 min at 37°(2  with 
constant shaking. A second aliquot of 50 ml of the washed platelet suspension was not incubated 
with thrombin. Both aliquots of platelets were then washed twice with the modified Ardlie II 
buffer, and each was then resuspended in the same buffer to 9 ml. 
Treatment of Platelets with Specific Antisera (Table I) 
EXPERIMENT  1.  The  thrombin-treated and  untreated control platelets were divided into 
three samples (A, B, and (3) of 3 ml each. Anti-GPIIIa [0.3 ml F(ab')2 20 #g/ml] was added to 
two samples (A and (3). KLH-conjugated anti-GPIIb [0.3 ml F(ab')2 14 #g/ml] was added to 
the third sample (B).  After incubation for 30 rain at 37°C, all platelet samples were washed 
twice with the modified Ardlie II buffer. To each of the samples that had been incubated with 
anti-GPIIIa (A and (2) was added 1.5 ml of the ferritin-conjugated F(ab')2 fraction of the goat 
anti-rabbit T-globulin (14.5/~g/ml). The mixtures were incubated for 30 rain at 37°C and the 
plateiets were washed twice with the Ardlie buffer. One sample each ((2) of thrombin-treated 
and  control platelets that  had  been  incubated with  the  ferritin antibody was  then  further 
incubated for 30 min at 370(3 with the KLH-conjugated anti-GPIIb (14 #g/ml) and washed 
twice with Ardlie buffer. 
EXPERIMENT 2.  GPIb,  another  major  platelet  membrane  glycoprotein not  involved  in 
platelet aggregation, was used as a control (1). The same procedure was used as in experiment 
1. Instead of using anti-GPIIIa antibody, 0.3 ml of the F(ab% fraction of anti-GPIb was used 
(46.5 #g/ml). The same KLH-conjugated anti-GPIIb was used at the same concentration as in 
experiment  1.  All platelet samples that  had  been  incubated  with  anti-GPIb were  further 
incubated with the ferritin-conjugated anti-rabbit -/-globulin. For the platelets that were to be 
double-labeled, the  sequence  of addition was  anti-GPIb, ferritin-conjugated anti-rabbit  y- 
TABLE  I 
Sequence of Addition of Antisera for the Morphologic Demonstration of Distribution of GPIb, GPlIb, and 
GPIIIa in the Unstimulated and Thrombin-stimulated Platelets 
Platelets  Sample 
Incubation step 
1  2  3 
Experiment 1  Thrombin-treated and  A  Anti-GPIIla*  Anti-rabbit y-globulin  -- 
untreated control  (Fe):~ 
B  Anti-GPIIb (KLH)§  -- 
C  Anti-GPllIa  Anti-rabbit "/-globulin  Anti-GPllb (KLH) 
(Fe) 
Experiment 2  Thrombin-treated and  A  Anti-GPlbll  Anti-rabbit y-globulin  -- 
untreated control  (Fe) 
B  Anti-GPIlb (KLH)  -- 
C  Anti-GPlb  Anti-rabbit "/-globulin  Anti-GPIIb (KLH) 
(Fe) 
* Anti-GPIlla: F(ab')2 fraction of rabbit antibody to platelet membrane OPIIla. 
Anti-rabbit y-globulin (Fe):  ferritin-conjugated F(ab')2 fraction of goat antibody to rabbit ),-globulin. 
§ Anti-GPlIb (KLH): KLH-conjugated F(ab')2 fraction of rabbit antibody to platelet membrane GP1Ib. 
I[ Anti-GPlb: F(ab')2 fraction of rabbit antibody to platelet membrane GPIb. For methodology, see text. 1060  PLATELET  GLYCOPROTEIN Ilb-Illa  COMPLEX ULTRASTRUCTURE 
globulin, and KLH-labeled anti-GPIIb (Table I). All incubation times and wash steps were the 
same as for experiment  1. 
Preparation of Membranes  for Electron Microscopy.  A sample of platelets  from each aliquot  was 
removed  and  was  frozen  and  thawed  three  times. The  resultant  platelet  membranes  were 
washed three times in a 1:10 dilution of normal saline. Samples to which the ferritin-conjugated 
antibody had been added were applied  to a copper grid coated with collodion and carbon, and 
stained with bismuth subnitrate (15); those that had been incubated with the KLH-conjugated 
antibody were stained with 2% uranyl acetate and applied  to the grids. Samples that contained 
both markers  were first stained  with  uranyl acetate,  and  after  application  to the grid  were 
further stained  with  bismuth subnitrate.  The grids were viewed under a Philips 301 electron 
microscope (Philips Electronic Instruments,  Inc., Mahwah, N.J.) at 80 kV. 
Results 
Morphologic Demonstration of GPIIIa Distribution in the Unstimulated and Thrombin-stimu- 
lated  Platelet  Membranes.  Fig.  1 A  demonstrates  the  distribution  of GPIIIa in  the 
unstimulated platelet membrane as evidenced by the indirect ferritin-labeling proce- 
dure. The ferritin molecules were scattered randomly over the platelet surface. There 
was a  very small amount of clustering, as indicated by occasional clumps of three to 
five  ferritin  molecules.  The  distribution  of GPIIIa in  the  platelet  membrane  after 
stimulation of the platelet  with thrombin is shown in Fig.  1 B.  Large clumps of the 
ferritin label  (indicated by white arrows) were visualized, indicating that membrane 
perturbation had resulted in the clustering of the GPIIIa molecules. 
Morphologic Demonstration of GPIIb Distribution in the Unstimulated and Thrombin-stimulated 
Platelet Membrane.  Fig.  2A demonstrates the distribution  of KLH-conjugated anti- 
GPIIb in  the  unstimulated  platelet  membrane.  Most  of the  KLH  molecules were 
randomly scattered over the surface of the membrane,  but  in addition  there was a 
small amount of clumping. Fig. 2 B shows the distribution of the same label when the 
platelets were stimulated with thrombin. Very large clumps of KLH molecules can be 
seen  (indicated  by  white  arrows),  indicating  that  as  was  the  case  with  GPIIIa, 
membrane perturbation resulted in clustering of the GPIIb molecules. 
Morphologic Demonstration of GPIIb-IIIa  Complex Formation in  the  Thrombin-stimulated 
Platelet Membrane.  Fig. 3 A demonstrates the distribution of GPIIb and GPIIIa in the 
unstimulated platelet as indicated by an indirect ferritin marker assay for anti-GPIIIa 
and  KLH conjugated to anti-GPIIb. Both labels  were randomly scattered  over the 
membrane surface.  However, after stimulation  of the platelet  with  thrombin,  large 
mixed clumps of ferritin and KLH were seen (KLH is indicated by the white arrows 
and  ferritin  is  indicated  by black/white arrows in  Fig.  3B), which indicate macro- 
molecular complex formation (co-clustering) between GPIIb and GPIIIa. 
Morphologic Demonstration of GPIb Distribution in the Unstimulated and Thrombin-stimulated 
Platelet Membrane.  Fig. 4A demonstrates the distribution of GPIb in the membrane 
of the unstimulated platelet  as evidenced by the indirect ferritin  assay. Most of the 
ferritin  marker is seen  in  clusters of 10-20 molecules, indicating that  unlike GPIIb 
and GPIIIa, which appear to be mainly randomly distributed  in the platelet  mem- 
brane,  the  distribution  of GPIb  is  primarily  focal.  After platelet  stimulation  with 
thrombin, very large clumps of ferritin  (indicated by white arrows)  were visualized, 
which indicated marked clustering of the GPIb molecules in the membrane (Fig. 4 B). 
Lack of Demonstrable Complex Formation between GPIb and GPIIb after Platelet Stimulation 
with  Thrombin.  Fig.  5A  demonstrates  the  distribution  of GPIb  and  GPIIb  in  the 
unstimulated platelet  membrane, as evidenced by an indirect ferritin assay for anti- POLLEY  ET  AL.  1061 
FIG.  1.  Platelets interacted with rabbit antibody to platelet membrane GPIIIa followed by ferritin- 
conjugated  goat  anti-rabbit  y-globulin.  (A),  untreated  platelets;  (B),  thrombin-treated platelets, 
stained  with  bismuth  subnitrate.  White  arrows  in  (B)  indicate clusters of ferritin  molecules,  x 
278,400.  Inserts ×  87,000. 1062  PLATELET  GLYCOPROTEIN  llb-IIia  COMPLEX  ULTRASTRUCTURE 
FIO.  2.  Platelets interacted with KLH conjugated to anti-platelet GPIIb. (A), untreated platelets; 
(B), thrombin-treated platelets, stained with uranyl acetate. White arrows in (B) indicate a typical 
large cluster of KLH molecules. ×  278,400.  Inserts ×  87,000. POLLEY  ET  AL.  1063 
Fio.  3.  Platelets  interacted  with  anti-GPIIIa,  ferritin  conjugated  goat  anti-rabbit  y-globulin; 
KLH-conjugated anti-GP IIb. Stained with uranyl acetate and bismuth subnitrate. (A), untreated 
platelets; (B), thrombin-treated platelets. In (B) can be seen mixed macromolecular co-clusters of 
ferritin molecules (black/white arrows) and KLH  molecules (white arrows).  ×  278,400.  Inserts × 
87,000. 1064  PLATELET  GLYCOPROTEIN  lib-Ilia  COMPLEX  ULTRASTRUCTURE 
FIo.  4.  Platelets interacted with rabbit antibody to platelet membrane GPIb (anti-GPIb), followed 
by ferritin-conjugated goat anti-rabbit y-globulin. (A), untreated platelets;  (B), thrombin-treated 
platelets. Stained with bismuth subnitrate. White arrows in  (B) indicate typical clusters of ferritin 
molecules, x  278,400.  Inserts X 87,000. POLLEY  ET  AL.  1065 
FIo.  5.  Platelets interacted with anti-GPIb; ferritin-conjugated goat anti-rabbit y-globulin; KLH- 
conjugated anti-GPIIb. Stained with uranyl acetate and bismuth subnitrate. (A), untreated platelets; 
(B)  and  (C),  thrombin-treated  platelets.  Typical  KLH  molecules in  (A)  are indicated  by white 
arrows. In (B)  can be seen clusters of ferritin molecules (black/white arrows) with some randomly 
distributed KLH molecules. In (C) another area of the same preparation is shown. In this area very 
large clusters of ferritin (black/white arrows) adjacent to very large clusters of KLH (white arrows) 
are shown. No mixed macromolecular complexes of ferritin and KLH were seen. ×  278,400. 1066  PLATELET  GLYCOPROTEIN  IIb-IIIa COMPLEX  ULTRASTRUCTURE 
GPIb and KLH conjugated to anti-GPIIb.  Fig.  5 B  and C  demonstrates the distri- 
bution of the two markers in the platelet membrane after thrombin stimulation. In 
Fig. 5 B, discrete clumps of ferritin (indicated by black/white arrows) were seen with 
no associated KLH molecules. In the same figure, some randomly distributed KLH 
molecules are shown. In another sample of the same preparation, very large clusters 
of ferritin (black/white arrows) adjacent to very large clusters of KLH (white arrows) 
were seen  (Fig.  5C).  No mixed clusters indicating complex formation between the 
two  glycoproteins were  seen  in  any  of the  areas  of the  preparation  subjected  to 
ultrastructural analysis. 
Discussion 
Because methods are now available for the isolation and purification of the platelet 
membrane glycoproteins GPIIb  and  GPIIIa, and  monospecific antisera  have been 
produced to them (8), it was possible to use an immunologic probe to study the spatial 
organization of these two glycoproteins in the platelet membrane. For the ultrastruc- 
tural studies, two immunologic markers were used: one was an indirect assay in which 
ferritin was conjugated to goat anti-rabbit y-globulin and used to localize the rabbit 
antibody to GPIIIa. The second ultrastructural label was KLH conjugated directly to 
anti-GPIIb. When both markers were used separately, the distribution of GPIIb and 
GPIIIa in the membrane of the unstimulated platelet was shown to be random with 
occasional small foci. After stimulation of the platelet with thrombin, large clusters of 
either ferritin or KLH were visualized, indicating that membrane perturbation had 
resulted in the clustering of GPIIb and GPIIIa molecules. 
In a  double-label experiment, it was possible to determine the topographic rela- 
tionship of the two separate glycoproteins to each other. In the unstimulated platelet 
membrane, random distribution of both labels was visualized. However, after stimu- 
lation of the platelet with thrombin, large mixed clusters of ferritin and KLH were 
seen. This observation indicated that thrombin treatment of the platelet had resulted 
in the formation of large clusters of GPIIb-GPIIIa complexes. 
The spatial organization of GPIb in the unstimulated platelet was different from 
that seen for GPIIb and GPIIIa. The GPIb glycoprotein was organized in microclusters 
in the resting platelet membrane surface. Thrombin treatment of the platelet mem- 
brane resulted in the formation of large clusters of GPIb molecules. In a double-label 
experiment, ferritin was used as the probe with anti-GPIb and KLH was used with 
anti-GPIIb. Large separate clumps of ferritin molecules and of KLH molecules were 
visualized. However, no mixed clusters of ferritin and KLH were seen, indicating that 
even though membrane perturbation induced by thrombin stimulation had resulted 
in the formation of large clusters of GPIb molecules, no complex between GPIb and 
GPIIb  was  formed.  The  data  suggest  that  the  formation  of the  GPIIb-GPIIIa 
macromolecular complex is a specific phenomenon associated with membrane stim- 
ulation. Other studies have also suggested a close association of GPIIb and GPIIIa in 
the stimulated platelet membrane. A  monoclonal antibody made to thrombin-stim- 
ulated platelets detected a  complex of the two proteins in Triton X-100-solubilized 
platelet membranes  (16). An identical result has been reported on crossed immuno- 
electrophoresis of solubilized platelet membrane proteins using a  polyspecific rabbit 
antibody (5). POLLEY ET AL.  1067 
Recent  studies  (17)  suggest that  receptor complex formation and clustering are 
important for signal generation after membrane stimulation. In some circumstances, 
ligand-induced membrane receptor clustering forms part  of a  membrane recycling 
pathway  (18).  In  view  of the  absence  of fibrinogen  binding  by  thrombasthenic 
platelets and the concomitant deficiency of GPIIb and GPIIIa in the disorder, it seems 
logical to assume that the thrombin-activated GPIIb-GPIIIa complex may function 
as the fibrinogen receptor in platelets. Preliminary studies in fact demonstrate complex 
formation of GPIIb-GPIIIa with purified human fibrinogen.  2 
Because GPIIb  and GPIIIa are  normally exposed  on  the  unstimulated platelet 
surface (1), which does not bind fibrinogen (2, 3, 6), platelet membrane perturbation 
should initiate new spatial and topographic relationships between these two glycopro- 
teins, which are probably necessary for the generation or induction of the fibrinogen 
receptors. Peerschke and Zucker (19) have shown that membrane fluidity and receptor 
clustering are necessary for fibrinogen binding and platelet aggregation. 
We  suggest  that  macromolecular  complex  formation  of GPIIb  and  GPIIIa  is 
necessary for the induction of the fibrinogen receptor in stimulated platelets. Further 
studies are currently under way to determine morphologically the spatial organization 
of fibrinogen to the GPIIb-GPIIIa complex in the activated platelet. 
Summary 
The topographic relationships of platelet membrane glycoprotein IIb and glyco- 
protein IIIa have been studied in stimulated and unstimulated human platelets using 
immunoelectron microscopy. An indirect approach with ferritin-conjugated goat anti- 
rabbit ,/-globulin was used to localize the rabbit antibody to glycoprotein IIIa. The 
second ultrastructural label was keyhole limpet hemocyanin conjugated directly to 
antibody to  glycoprotein IIb.  Using  the  double  labels,  it  was  demonstrated  that 
glycoprotein IIb and glycoprotein IIIa were distributed randomly in the unstimulated 
platelet membrane. After platelet stimulation with thrombin, large clusters of glyco- 
protein IIb-glycoprotein IIIa complexes were formed. No complex formation between 
glycoprotein Ib  and  glycoprotein IIb  was  observed  in  control  experiments.  These 
observations suggest that thrombin stimulation initiates the specific glycoprotein IIb- 
glycoprotein IIIa macromolecular complex formation on the platelet surface, which 
may act as the active fibrinogen-binding site required for normal platelet aggregation. 
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